• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR Back to Search Results
Catalog Number SGC0302
Device Problem Off-Label Use (1494)
Patient Problem Atrial Perforation (2511)
Event Date 08/14/2020
Event Type  Injury  
Manufacturer Narrative
The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.(b)(4).
 
Event Description
This is being filed to report the atrial septal defect requiring intervention.It was reported that this was a mitraclip procedure to treat tricuspid regurgitation (tr) with a grade of 3.One clip was implanted, reducing tr to 1-2.After the clip delivery system (cds) was removed, it was noted there was an atrial septal defect (asd).An occluder was placed to treat the asd.There was no clinically significant delay in the procedure and no adverse patient effects.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Based on the available information, the reported atrial perforation was due to procedural conditions.It should be noted that the mitraclip ifu states: the mitraclip nt system is intended for reconstruction of the insufficient mitral valve through tissue approximation.The off-label use does not appear to have contributed to the reported issue.The reported patient effect of atrial septal defect requiring intervention as listed in the mitraclip nt system instructions for use (ifu), is a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10488057
MDR Text Key205491590
Report Number2024168-2020-07334
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/06/2021
Device Catalogue NumberSGC0302
Device Lot Number00406U104
Was Device Available for Evaluation? No
Date Manufacturer Received09/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
1 IMPLANTED MITRACLIP; 1 IMPLANTED MITRACLIP
Patient Outcome(s) Required Intervention;
-
-